Winning the go-to-market game: Standing out in tomorrow’s complex healthcare ecosystems
Ahead of Reuters Pharma 2022, Antonio Iervolino, Partner out of our Putnam London office describes 5 major shifts that pharma companies will have to embrace as they design the path to market for their novel assets and provides an analysis on pharma product launches since 2018, identifying trends and measuring their performance against pre-launch expectations.
Antonio distills the key drivers that are critical in developing a virtuous value creating system and designing impactful go-to-market strategies for tomorrow’s healthcare ecosystems.
Read more on the thoughtful analysis and hear from Antonio at Pharma 2022 next week.
Jump to a slide with the slide dots.
Sneha Dutta
Breaking Barriers: The Role of Medical Affairs in Driving Health Equity
Health equity in pharma: Addressing disparities via diversity in trials, access to care, RWE, tech innovation, and cross-functional collaboration.
Read more
Mike Harvey
Insights from digital trends at ASH 2024 using ClarityNav, a proprietary AI-driven platform
Introduction The 2024 American Society of Hematology (ASH) Annual Meeting presented a wealth of data, unveiling the...
Read more
Mohan Chukkapalli
Sunny side up – Biotech funding – 2025 & Beyond
Putnam shares key questions to consider in preparation of advancing trials and deals that have been put on hold.
Read more